SIEMENS MULTIVIEW INFINITY TELEMETRY SYSTEM ENHANCEMENT, ADDITIONAL ARRHYTHMIA CALLS

K983980 · Siemens Medical Solutions USA, Inc. · DSI · Nov 16, 1998 · Cardiovascular

Device Facts

Record IDK983980
Device NameSIEMENS MULTIVIEW INFINITY TELEMETRY SYSTEM ENHANCEMENT, ADDITIONAL ARRHYTHMIA CALLS
ApplicantSiemens Medical Solutions USA, Inc.
Product CodeDSI · Cardiovascular
Decision DateNov 16, 1998
DecisionSESE
Submission TypeSpecial
Regulation21 CFR 870.1025
Device ClassClass 2
AttributesPediatric

Intended Use

Use of the MultiView WorkStation Infinity Telemetry System is indicated for adult and pediatric patient populations in an environment where patient care is provided by Healthcare Professionals (Physicians, Nurses, Technicians) when the professional determines that a device is required to measure and produce visual and audible alarms for any one or more of the following parameters: - Heart rate ● - ECG Arrhythmia Analysis . - Arterial oxygen saturation . - . Pulse rate - ST segment analysis . The device is intended to be used in the environment where patient care is provided by Healthcare Professionals, i.e. Physicians, Nurses, and Technicians, who will determine when use of the device is indicated, based upon their professional assessment of the patient's medical condition.

Device Story

The Siemens MultiView WorkStation Infinity Telemetry System is a cardiac monitoring platform used in clinical environments by physicians, nurses, and technicians. It receives physiological signals—specifically ECG, pulse rate, and arterial oxygen saturation—from patients. The system processes these inputs to provide real-time monitoring, arrhythmia detection, and ST segment analysis. It generates visual and audible alarms to alert healthcare providers to changes in patient status. The device modification enables specific arrhythmia calls: Pause, Bradycardia, and Tachycardia. Clinicians use the output to assess patient condition and make clinical decisions. The system is not MRI compatible.

Clinical Evidence

No clinical data provided; bench testing only.

Technological Characteristics

Cardiac monitoring system for ECG, pulse rate, SpO2, and ST segment analysis. Features arrhythmia detection and alarm functionality. Not MRI compatible. Software-based signal processing for physiological parameters.

Indications for Use

Indicated for adult and pediatric patients requiring monitoring of heart rate, ECG arrhythmia, arterial oxygen saturation, pulse rate, or ST segment analysis in clinical settings under the supervision of healthcare professionals.

Regulatory Classification

Identification

The arrhythmia detector and alarm device monitors an electrocardiogram and is designed to produce a visible or audible signal or alarm when atrial or ventricular arrhythmia, such as premature contraction or ventricular fibrillation, occurs.

Special Controls

*Classification.* Class II (special controls). The guidance document entitled “Class II Special Controls Guidance Document: Arrhythmia Detector and Alarm” will serve as the special control. See § 870.1 for the availability of this guidance document.

Predicate Devices

Related Devices

Submission Summary (Full Text)

{0}------------------------------------------------ K983980 # Special 510(k): Device Modification Siemens MultiView WorkStation Infinity Telemetry System ## 510(k) SUMMARY as required per 807.92(c) Submitters Name, Address: Siemens Medical Systems, Inc. Electromedical Systems Group, PCS Danvers, MA 01923 Tel: (978) 907-7500 Fax: (978) 750-6879 Official Correspondent: David Simard, Director Quality Assurance & Regulatory Affairs Contact person for this submission: Penelope H. Greco Date submission was prepared: November 5, 1998 Trade Name, Common Name and Classification Name: A. Trade Name: Siemens MultiView WorkStation Infinity Telemetry System #### B. Common Name, Classification Name, Class and Regulation Number: | Common Name | Classification<br>Number | Class | Regulation Number | |-----------------------------------------------------------------|--------------------------|-------|-------------------| | Cardiac monitor | 74DRT | II | 21 CFR 870.2300 | | Pulse rate monitor | 74BWS | II | 21 CFR 870.2300 | | Pulse oximeter | 74DQA | II | 21 CFR 870.2700 | | Radiofrequency physiological signal transmitter and<br>receiver | 74DRG | II | 21 CFR 870.2910 | | Arrhythmia detector & Alarm | 74DSI | III | 21 CFR 870.1025 | | Medical Cathode-Ray Tube Display | 74DXJ | II | 21 CFR 870.2450 | | ST Segment Monitor with Alarm | 74MLD | III | 21 CFR 870.1025 | Legally Marketed Device Identification: Siemens MultiView WorkStation Infinity Telemetry System Description of Modification: The MultiView WorkStation Infinity Telemetry System, 510(k) K972714, has been modified to enable the Pause, Bradycardia, and Tachycardia Arrhythmia calls. Intended Use: (Same as K972714) Biocompatability: Not applicable Sterilization: Not applicable Standards and Guidances: (Same as K972714) #### COMPANY CONFIDENTIAL ## Siemens Medical Systems, Inc. Electromedical Systems Group, PCS 16 Electronics Avenue Danvers, MA 01923 USA Tel: (978) 907-7500 Fax: (978) 750-6879 Telex: 511958 (Siemensm SD) {1}------------------------------------------------ Image /page/1/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo is circular, with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES USA" arranged around the perimeter. In the center of the circle is a stylized image of three human profiles facing to the right, stacked on top of each other. Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 NOV 1 6 1998 Mr. David Simard Siemens Medical Systems, Inc. 16 Electronics Avenue Danvers, MA 01923 K983980 Re: Siemens MultiView Workstation Infinity Telemetry System Regulatory Class: III (three) Product Code: 74 DSI Dated: November 5, 1998 Received: November 9, 1998 Dear Mr. Simard: We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual reqistration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major requlations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the Current Good Manufacturing Practice requirements, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic QS inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in requlatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations. {2}------------------------------------------------ Page 2 - Mr. David Simard This letter will allow you to beqin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling requlation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4648. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597, or at its internet address "http://www.fda.gov/cdrh/dsma/dsmamain.html". Sincerely yours, Thomas J. Callahan Thomas J. Čallahan, Ph.D. Director Division of Cardiovascular, Respiratory, and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {3}------------------------------------------------ # 510(k) Number (if known):_K983980 Device Name: __ Siemens MultiView WorkStation Infinity Telemetry System Indications for Use: (Same as K972714) Use of the MultiView WorkStation Infinity Telemetry System is indicated for adult and pediatric patient populations in an environment where patient care is provided by Healthcare Professionals (Physicians, Nurses, Technicians) when the professional determines that a device is required to measure and produce visual and audible alarms for any one or more of the following parameters: - Heart rate ● - ECG Arrhythmia Analysis . - Arterial oxygen saturation . - . Pulse rate - ST segment analysis . The device is intended to be used in the environment where patient care is provided by Healthcare Professionals, i.e. Physicians, Nurses, and Technicians, who will determine when use of the device is indicated, based upon their professional assessment of the patient's medical condition. #### MRI Compatibility Statement: The MultiView WorkStation Infinity Telemetry System is not compatible for use in a MRI magnetic field. (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) Prescription Use (Per 21 CFR 801.109) OR Over-The-Counter Use (Optional Format 1-2-96) Krave (Division Sign-Off) Division of Cardiovascular, Respiratory, and Neurological Devices 510(k) Number _
Innolitics
510(k) Summary
Decision Summary
Classification Order
Enter a record ID and click Load to view the document.
100%